Comparative Efficacy and Safety of Programmed Death-1 Pathway Inhibitors in Advanced Gastroesophageal Cancers: A Systematic Review and Network Meta-Analysis of Phase III Clinical Trials

SIMPLE SUMMARY: The use of checkpoint inhibitors has changed the treatment landscape for gastroesophageal cancer in the third-line setting. However, success rates in earlier treatment lines are highly variable across trials. Herein, we compare the efficacy and safety of the different anti-PD-1/PD-L1...

Descripción completa

Detalles Bibliográficos
Autores principales: da Silva, Laercio Lopes, Aguiar, Pedro Nazareth, Park, Robin, Edelman Saul, Eduardo, Haaland, Benjamin, de Lima Lopes, Gilberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199431/
https://www.ncbi.nlm.nih.gov/pubmed/34073475
http://dx.doi.org/10.3390/cancers13112614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199431/
https://www.ncbi.nlm.nih.gov/pubmed/34073475
http://dx.doi.org/10.3390/cancers13112614

Ejemplares similares